Page last updated: 2024-10-23

bretylium and Acute Disease

bretylium has been researched along with Acute Disease in 1 studies

bretylium: RN given refers to parent cpd
bretylium : A quaternary ammonium cation having 2-bromobenzyl, ethyl and two methyl groups attached to the nitrogen. It blocks noradrenaline release from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibrillation.

Acute Disease: Disease having a short and relatively severe course.

Research Excerpts

ExcerptRelevanceReference
"Cisapride was ineffective at 1 mg/kg but caused a partial reversal at the 5- and 10-mg/kg doses (46."1.30Acute intracranial hypertension-induced inhibition of gastric emptying: evaluation in conscious rats. ( Gupta, YK; Kacker, V; Mehta, VS, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kacker, V1
Mehta, VS1
Gupta, YK1

Other Studies

1 other study available for bretylium and Acute Disease

ArticleYear
Acute intracranial hypertension-induced inhibition of gastric emptying: evaluation in conscious rats.
    European journal of pharmacology, 1999, Mar-12, Volume: 369, Issue:1

    Topics: Acute Disease; Analgesics, Non-Narcotic; Animals; Antihypertensive Agents; Antipsychotic Agents; Bre

1999